Vilin Bio Med logo

Vilin Bio Med

VILINBIO NSE
₹54.50 2.45 (4.71%)
Market Cap
₹83.11 Cr
P/E
24.77

Key Fundamentals

SMEPharmaceuticalsHealthcare
Market Cap
₹83.11 Cr
P/E (TTM)
24.77
EBITDA
₹3.20 Cr
Return on Equity
6.8%
Debt to Equity
0.01
Book Value
₹18.60
EPS (TTM)
₹2.20
52W High
₹60.95
52W Low
₹18.95

Price-based figures as of 13 Oct 2026, 15:19 IST · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,770.7035.134,24,850 Cr5.080.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,285.0084.272,46,488 Cr14.710.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,642.9072.891,76,601 Cr21.000.82%12.16%9.06%15,391 Cr2,156 Cr
Zydus Life Science
₹1,132.5025.201,12,967 Cr4.170.09%16.99%19.24%28,515 Cr4,593 Cr
Laurus Labs
₹2,059.40101.751,11,272 Cr21.000.10%16.38%19.67%7,323 Cr1,090 Cr
Cipla
₹1,329.6031.851,07,413 Cr3.121.00%11.21%14.88%28,786 Cr3,356 Cr
Dr Reddys Laboratories
₹1,240.0032.121,03,500 Cr2.720.67%10.87%13.94%34,555 Cr3,184 Cr
Mankind Pharma
₹2,372.0047.9597,974 Cr6.010.04%11.70%13.78%15,074 Cr2,067 Cr
Aurobindo Pharma
₹1,684.6026.2896,928 Cr2.560.24%9.25%13.58%35,390 Cr3,711 Cr
Lupin
₹1,953.6016.1589,336 Cr3.980.92%23.79%28.42%30,017 Cr5,552 Cr
Vilin Bio Med (this company)
₹54.5024.7783 Cr2.930.00%6.80%10.21%8 Cr1 Cr
Median 11 companies₹1,770.7032.121,07,413 Cr4.170.32%12.16%14.88%28,515 Cr3,184 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-12
v2.0.0
59 Good
Overall score
Data confidence 100/100

Category scores

Quality Good 58
Returns, margins, earnings quality 22%
Valuation Poor 36
Cheap vs sector & own history 24%
Growth Strong 99
Sales & profit trajectory 9%
Financial Health Strong 75
Solvency, leverage, coverage 9%
Momentum Strong 94
Trend strength, vol-adjusted 12%
Ownership Average 50
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company has reduced debt.
  • Company is almost debt free.

Weaknesses

4
  • Stock is trading at 2.80 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.92%
  • Company has a low return on equity of 3.53% over last 3 years.

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

BearishNeutralBullish

Bullish

Bearish
6
Neutral
6
Bullish
7

Moving Averages

BearishNeutralBullish

Bullish

Bearish
4
Neutral
0
Bullish
6

Growth Rate

Revenue Growth
176% higher than 3Y

change over 1 year

Net Income Growth
850% higher than 3Y

change over 1 year

Cash Flow Change
233%

change over 1 year

EBITDA Margin Change
-8.03%

change over 1 year Operating margin 8.77% · Mar 2026

Quarterly Results

Particulars Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
4.95
4.1
8.21
7.65
8.16
4.49
10.32
9.66
32.6
Expenses
4.56
2.99
6.74
6.26
8.73
4.07
9.95
9.32
29.74
Operating Profit
0.39
1.11
1.47
1.39
-0.57
0.42
0.37
0.34
2.86
OPM %
7.88%
27.07%
17.9%
18.17%
-6.99%
9.35%
3.59%
3.52%
8.77%
Other Income
0
0
0.02
0.11
0.22
0.22
0.25
0
0
Interest
0.25
0.32
0.33
0.38
0.41
0.41
0.44
0.07
0
Depreciation
0.11
0.08
0.08
0.08
0.05
0.07
0.03
0.07
0.21
PBT
0.03
0.71
1.08
1.04
-0.81
0.16
0.15
0.2
2.65
Tax %
33.33%
21.13%
35.19%
25.96%
-25.93%
18.75%
33.33%
25%
32.83%
Net Profit
0.02
0.55
0.69
0.77
-0.61
0.12
0.1
0.15
1.78
EPS (₹)
0.06
1.67
0.69
0.55
-0.44
0.09
0.07
0.11
1.17
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
16.62
11.54
11.21
12.31
15.8
14.81
42.26
Expenses
15.71
10.68
10.44
9.73
14.97
14.02
39.06
Operating Profit
0.91
0.86
0.77
2.58
0.83
0.79
3.2
OPM %
5.48%
7.45%
6.87%
20.96%
5.25%
5.33%
7.57%
Other Income
0.01
0
0
0.02
0.32
0.47
0
Interest
0.41
0.44
0.51
0.65
0.79
0.85
0.07
Depreciation
0.31
0.26
0.22
0.17
0.13
0.1
0.28
PBT
0.2
0.16
0.04
1.78
0.23
0.31
2.85
Tax %
20%
25%
25%
30.34%
26.09%
25.81%
31.93%
Net Profit
0.16
0.12
0.03
1.25
0.16
0.22
1.93
EPS (₹)
0.48
0.36
0.09
1.26
0.11
0.16
1.27
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.3
3.3
3.3
9.95
13.95
13.95
15.25
Reserves
3.94
4.06
4.1
0.73
8.89
9.11
13.12
Borrowings
4.53
5.52
5.3
4.93
6.83
2.57
0.21
Other Liabilities
2.24
1.01
0.86
2.07
2.73
2.15
6.36
Total Liabilities
14.01
13.89
13.56
17.68
32.4
27.78
34.94
Fixed Assets
2.13
1.87
1.65
1.51
1.38
1.28
2.87
CWIP
0
0
0
0
0
1.57
0
Investments
0
0
0
0
0
0
0
Other Assets
11.88
12.02
11.91
16.17
31.02
24.93
32.07
Total Assets
14.01
13.89
13.56
17.68
32.4
27.78
34.94
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-1.46
-1
0.21
-1.66
-7.42
0.21
0.7
Investing
-0.02
0
0
-0.03
0.32
-1.11
-0.3
Financing
1.51
0.98
-0.22
1.68
8.87
-5.1
1.01
Net Cash Flow
0.03
-0.02
-0.01
0
1.77
-5.99
1.41
Free Cash Flow
-1.48
-1
0.21
-1.69
-7.42
-1.36
0.4
CFO/OP
-156
-112
29
-43
-888
35
49
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
160
242
254
166
131
211
138
Inventory Days
56.13
83.17
93.82
44.74
125
120
70.03
Days Payable
49.48
33.11
26.34
60.49
54.71
39.02
32.59
Cash Conversion Cycle
166
292
321
150
202
291
175
Working Capital Days
111
204
212
45.07
76.23
375
168
ROCE %
—
4.87%
4.3%
17.17%
4.51%
4.2%
10.77%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vilin Bio Med insights

57 extracted metrics + investor summaries across FY20–FY26.

Log in — free

Shareholding Pattern

Promot.56.65%Others10.27%Public33.08%As ofJun 2026

Documents

Frequently Asked Questions about Vilin Bio Med

What does Vilin Bio Med Ltd do?
Incorporated in 2005, Vilin Bio Med Ltd is in the business of manufacturing and selling of pharmaceutical products[1]
Where is Vilin Bio Med Ltd (VILINBIO) listed?
Vilin Bio Med Ltd trades as VILINBIO on the NSE.
Which sector does Vilin Bio Med Ltd belong to?
Vilin Bio Med Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Vilin Bio Med Ltd?
Vilin Bio Med Ltd has a market capitalisation of ₹83.11 Cr as of 13 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Vilin Bio Med Ltd?
Vilin Bio Med Ltd trades at a PE ratio of 24.77 as of 13 Oct 2026, on earnings per share of ₹2.2, against a book value of ₹18.6 per share.
What is the 52-week high and low of Vilin Bio Med Ltd?
Over the last 52 weeks Vilin Bio Med Ltd has traded between ₹18.95 and ₹60.95 as of 13 Oct 2026.
What is the Return on Equity (ROE) of Vilin Bio Med Ltd?
Vilin Bio Med Ltd reported a return on equity of 6.80%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 2005, Vilin Bio Med Ltd is in the business of manufacturing and selling of pharmaceutical products[1]

Website vilinbiomed.co.in
Listed 2023-06-30
Face Value ₹ 10
Shares Outstanding 1,52,50,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VILINBIO.md for Vilin Bio Med Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List